Trastuzumab in advanced breast cancer – a decade of experience in Germany

por Jackisch, Christian, Schoenegg, Winfried, Reichert, Dietmar, Welslau, Manfred, Selbach, Johannes, Harich, Hanns-Detlev, Tesch, Hans, Wohlfarth, Tim, Eustermann, Heidi, Hinke, Axel
Publicado en BMC Cancer (2014)

Trastuzumab in Human Epidermal Growth Factor Receptor 2‐Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 i...

por Dall, Peter, Koch, Thorsten, Göhler, Thomas, Selbach, Johannes, Ammon, Andreas, Eggert, Jochen, Gazawi, Nidal, Rezek, Daniela, Wischnik, Arthur, Hielscher, Carsten, Keitel, Stella, Cirrincione, Ursula, Hinke, Axel, Feisel‐Schwickardi, Gabriele
Publicado en Oncologist (2017)

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

por Dall, Peter, Koch, Thorsten, Göhler, Thomas, Selbach, Johannes, Ammon, Andreas, Eggert, Jochen, Gazawi, Nidal, Rezek, Daniela, Wischnik, Arthur, Hielscher, Carsten, Schleif, Nicolas, Cirrincione, Ursula, Hinke, Axel, Feisel-Schwickardi, Gabriele
Publicado en BMC Cancer (2018)

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera

por Schnittger, Susanne, Bacher, Ulrike, Haferlach, Claudia, Geer, Thomas, Müller, Peter, Mittermüller, Johann, Petrides, Petro, Schlag, Rudolf, Sandner, Reiner, Selbach, Johannes, Slawik, Hans Rainer, Tessen, Hans Werner, Wehmeyer, Jürgen, Kern, Wolfgang, Haferlach, Torsten
Publicado 2009